Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Blocking interferon-gamma might help treat various autoimmune diseases.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

ILC1 cells contribute to hair loss in alopecia areata.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.